Inventor profile of:

Scott D. Seiwert

City:

Pacifica, California

Country:

United States

Published Applications:

28

Last publication date:

2013-06-13

Top Assignees for applications by Scott D. Seiwert

The entities that hold a legal rights for patent applications filed by inventor Seiwert Scott D.:

Recent patent applications by Seiwert Scott D.

Scott D. Seiwert from Pacifica, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2013-06-13
US20130150426A1
Chemistry; metallurgy

METHODS OF DIAGNOSING AND TREATING IDIOPATHIC PULMONARY FIBROSIS

#2 | 2013-04-25
US20130102597A1
Chemistry; metallurgy

Compounds and methods for treating inflammatory and fibrotic disorders

#3 | 2012-10-11
US20120258924A1
Human necessities

Method of modulating stress-activated protein kinase system

#4 | 2012-10-04
US20120251493A1
Human necessities

NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION

#5 | 2012-08-16
US20120208995A1
Chemistry; metallurgy

Macrocyclic inhibitors of hepatitis C virus replication

#6 | 2012-04-19
US20120094897A1
Chemistry; metallurgy

NOVEL INHIBITORS OF HEPATITIS C VIRUS REPLICATION

#7 | 2012-02-23
US20120046321A1
Human necessities

METHODS OF TREATING ATRIAL FIBRILLATION WITH P38 INHIBITOR COMPOUNDS

#8 | 2011-12-22
US20110312996A1
Chemistry; metallurgy

NOVEL INHIBITORS OF HEPATITIS C VIRUS REPLICATION

#9 | 2011-07-21
US20110177026A1
Human necessities

Use of Alpha-Glucosidase Inhibitors to Treat Alphavirus Infections

#10 | 2011-06-23
US20110152246A1
Chemistry; metallurgy

NOVEL INHIBITORS OF HEPATITIS C VIRUS REPLICATION

#11 | 2011-03-10
US20110059047A1
Chemistry; metallurgy

NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION

#12 | 2011-01-13
US20110008289A1
Chemistry; metallurgy

HYPERGLYCOSYLATED POLYPEPTIDE VARIANTS AND METHODS OF USE

#13 | 2010-09-23
US20100240704A1
Human necessities

METHOD OF MODULATING STRESS-ACTIVATED PROTEIN KINASE SYSTEM

#14 | 2010-04-22
US20100099851A1
Human necessities

SYNTHETIC HYPERGLYCOSYLATED, PROTEASE-RESISTANT POLYPEPTIDE VARIANTS, ORAL FORMULATIONS AND METHODS OF USING THE SAME

#15 | 2010-02-04
US20100029578A1
Human necessities

Methods of Treating Atrial Fibrillation with P38 Inhibitor Compounds

#16 | 2009-12-24
US20090318455A1
Chemistry; metallurgy

Compounds and methods for treating inflammatory and fibrotic disorders

#17 | 2009-10-29
US20090269305A1
Chemistry; metallurgy

Macrocyclic inhibitors of hepatitis C virus replication

#18 | 2009-07-02
US20090169510A1
Chemistry; metallurgy

NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION

#19 | 2009-06-11
US20090148407A1
Chemistry; metallurgy

Novel Macrocyclic Inhibitors of Hepatitis C Virus Replication

#20 | 2009-04-09
US20090093533A1
Chemistry; metallurgy

Compounds and methods for inhibiting hepatitis C viral replication

#21 | 2009-02-19
US20090047246A1
Chemistry; metallurgy

NOVEL INHIBITORS OF HEPATITIS C VIRUS REPLICATION

#22 | 2007-05-24
US20070117841A1
Human necessities

Use of pirfenidone in therapeutic regimens

#23 | 2007-03-08
US20070054842A1
Chemistry; metallurgy

Macrocyclic inhibitors of hepatitis C virus replication

#24 | 2006-11-30
US20060270612A1
Human necessities

Method of modulating stress-activated protein kinase system

#25 | 2006-11-30
US20060269517A1
Human necessities

Use of alpha-glucosidase inhibitors to treat alphavirus infections

#26 | 2006-09-14
US20060204473A1
Chemistry; metallurgy

Hyperglycosylated polypeptide variants and methods of use

#27 | 2006-08-17
US20060182716A1
Human necessities

Synthetic hyperglycosylated, protease-resistant polypeptide variants, oral formulations and methods of using the same

#28 | 2006-01-26
US20060018875A1
Human necessities

Interferon compositions and methods of use thereof

InventorID:

211269 ⎘